Duration of Objective Responses for Patients with Indolent Non-Hodgkin Lymphoma Discontinuing Treatment before Progression: Analysis from the Phase III Chronos-3 Trial Comparing Copanlisib Plus Rituximab with Placebo Plus Rituximab
| Autor: | Matasar, Matthew J., Capra, Marcelo, Özcan, Muhit, Lv, Fangfang, Li, Wei, Yañez, Eduardo, Sapunarova, Katya, Lin, Tongyu, Jin, Jie, Jurczak, Wojciech, Hamed, Aryan, Wang, Ming-Chung, Mongay Soler, Lidia, Cao, Anjun, Hiemeyer, Florian, Childs, Barrett H, Shi, Yuankai, Zinzani, Pier Luigi Luigi |
|---|---|
| Zdroj: | In Blood 23 November 2021 138 Supplement 1:3538-3538 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|